Nectar Lifesciences Limited (NLL), founded in June 1995 by Mr. Sanjiv Goyal, is a leading Indian pharmaceutical company specializing in the manufacturing of generic drug products, particularly oral and sterile cephalosporin antibiotics. The company operates state-of-the-art cGMP-compliant facilities approved by regulatory authorities such as the USFDA, EUGMP, PMDA, and KFDA. With a significant global presence, NLL exports to over 45 countries and has been recognized among the top midsized pharmaceutical companies in India. NLL is publicly listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) of India. :contentReference[oaicite:0]{index=0}